Primary episodic ataxias: Diagnosis, pathogenesis and treatment

Brain

Volumn 130, Issue 10, 2007, Pages 2484-2493

  Jen, J C ^a   Graves, T D ^b   Hess, E J ^c   Hanna, M G ^b   Griggs, R C ^d   Baloh, R W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Channelopathies; Episodic ataxia; Review

Indexed keywords

1 ETHYL 2 BENZIMIDAZOLINONE; 3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; ACETAZOLAMIDE; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CARBAMAZEPINE; CARBONATE DEHYDRATASE INHIBITOR; FLUNARIZINE; PLACEBO; POTASSIUM CHANNEL KV1.1; VALPROIC ACID;

ADD ON THERAPY; ALLELE; ALPHA CHAIN; ATAXIA; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; EPILEPSY; FEASIBILITY STUDY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC TRAIT; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MEDICAL LITERATURE; MIGRAINE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCREENING;

ANIMALS; CALCIUM CHANNELS; CEREBELLAR ATAXIA; DIAGNOSIS, DIFFERENTIAL; DISEASE MODELS, ANIMAL; GENOTYPE; HUMANS; KV1.1 POTASSIUM CHANNEL; MICE; MUTATION; PHENOTYPE;

EID: 34848869371     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awm126     Document Type: Review

References (71)

1. Adelman JP, Bond CT, Pessia M, Maylie J. Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 1995; 15: 1449-54.
2. Baloh RW, Yue Q, Furman JM, Nelson SF. Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 1997; 41: 8-16.
3. Boel M, Casaer P. Familial periodic ataxia responsive to flunarizine. Neuropediatrics 1988; 19: 218-20.
4. Bourinet E, Soong TW, Sutton K, Slaymaker S, Mathews E, Monteil A, et al. Splicing of alpha 1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat Neurosci 1999; 2: 407-15.
5. Browne DL, Gancher ST, Nutt JG, Brunt ER, Smith EA, Kramer P, et al. Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 1994; 8: 136-40.
6. Browne DL, Brunt ER, Griggs RC, Nutt JG, Gancher ST, Smith EA, et al. Identification of two new KCNA1 mutations in episodic ataxia/ myokymia families. Hum Mol Genet 1995; 4: 1671-2.
7. Brunt ER, van Weerden TW. Familial paroxysmal kinesigenic ataxia and continuous myokymia. Brain 1990; 113 (Pt 5): 1361-82.
8. Cader MZ, Steckley JL, Dyment DA, McLachlan RS, Ebers GC. A genome-wide screen and linkage mapping for a large pedigree with episodic ataxia. Neurology 2005; 65: 156-8.
9. Cao YQ, Piedras-Renteria ES, Smith GB, Chen G, Harata NC, Tsien RW. Presynaptic Ca2+ channels compete for channel type-preferring slots in altered neurotransmission arising from Ca2+ channelopathy. Neuron 2004; 43: 387-400.
10. Cao YQ, Tsien RW. Effects of familial hemiplegic migraine type 1 mutations on neuronal P/Q-type Ca2+ channel activity and inhibitory synaptic transmission. Proc Natl Acad Sci USA 2005; 102: 2590-5.
11. Chen H, von Hehn C, Kaczmarek LK, Ment LR, Pober BR, Hisama FM. Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia. Neurogenetics 2007; 8: 131-5. Epub 2006 Nov 29.
12. Damji KF, Allingham RR, Pollock SC, Small K, Lewis KE, Stajich JM, et al. Periodic vestibulocerebellar ataxia, an autosomal dominant ataxia with defective smooth pursuit, is genetically distinct from other autosomal dominant ataxias. Arch Neurol 1996; 53: 338-44.
13. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003; 33: 192-6.
14. Denier C, Ducros A, Vahedi K, Joutel A, Thierry P, Ritz A, et al. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology 1999; 52: 1816-21.
15. Ducros A, Denier C, Joutel A, Cecillon M, Lescoat C, Vahedi K, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 2001; 345: 17-24.
16. Eunson LH, Rea R, Zuberi SM, Youroukos S, Panayiotopoulos CP, Liguori R, et al. Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 2000; 48: 647-56.
17. Eunson LH, Graves TD, Hanna MG. New calcium channel mutations predict aberrant RNA splicing in episodic ataxia. Neurology 2005; 65: 308-10.
18. Farmer TW, Mustian VM. Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations. Arch Neurol 1963; 8: 471-80.
19. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD Jr, Hawkes R, Frankel WN, et al. Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 1996; 87: 607-17.
20. Fureman BE, Jinnah HA, Hess EJ. Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol Biochem Behav 2002; 73: 631-7.
21. Fureman BE, Hess EJ. Noradrenergic blockade prevents attacks in a model of episodic dysfunction caused by a channelopathy. Neurobiol Dis 2005; 20: 227-32.
22. Geschwind DH, Perlman S, Figueroa KP, Karrim J, Baloh RW, Pulst SM. Spinocerebellar ataxia type 6. Frequency of the mutation and genotype-phenotype correlations. Neurology 1997; 49: 1247-51.
23. Griggs RC, Engel WK, Resnick JS. Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann Intern Med 1970; 73: 39-48.
24. Griggs RC, Moxley RT 3rd, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978; 28: 1259-64.
25. Hans M, Luvisetto S, Williams ME, Spagnolo M, Urrutia A, Tottene A, et al. Functional consequences of mutations in the human alpha1A calcium channel subunit linked to familial hemiplegic migraine. J Neurosci 1999; 19: 1610-9.
26. Hoebeek FE, Stahl JS, van Alphen AM, Schonewille M, Luo C, Rutteman M, et al. Increased noise level of purkinje cell activities minimizes impact of their modulation during sensorimotor control. Neuron 2005; 45: 953-65.
27. Imbrici P, Eunson LH, Graves TD, Bhatia KP, Wadia NH, Kullmann DM, et al. Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A. Neurology 2005; 65: 944-6.
28. Ishikawa K, Fujigasaki H, Saegusa H, Ohwada K, Fujita T, Iwamoto H, et al. Abundant expression and cytoplasmic aggregations of [alpha]1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum Mol Genet 1999; 8: 1185-93.
29. Jen JC, Yue Q, Karrim J, Nelson SF, Baloh RW. Spinocerebellar ataxia type 6 with positional vertigo and acetazolamide responsive episodic ataxia. J Neurol Neurosurg Psychiatry 1998; 65: 565-8.
30. Jen JC, Yue Q, Nelson SF, Yu H, Litt M, Nutt J, et al. A novel nonsense mutation in CACNA1A causes episodic ataxia and hemiplegia. Neurology 1999; 53: 34-7.
31. Jen JC, Wan J, Graves M, Yu H, Mock AF, Coulin CJ, et al. Loss-offunction EA2 mutations are associated with impaired neuromuscular transmission. Neurology 2001; 57: 1843-8.
32. Jen JC, Kim GW, Baloh RW. Clinical spectrum of episodic ataxia type 2. Neurology 2004a; 62: 17-22.
33. Jen JC, Kim GW, Dudding KA, Baloh RW. No mutations in CACNA1A and ATP1A2 in probands with common types of migraine. Arch Neurol 2004b; 61: 926-8.
34. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005; 65: 529-34.
35. Jodice C, Mantuano E, Veneziano L, Trettel F, Sabbadini G, Calandriello L, et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 1997; 6: 1973-8.
36. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbio A, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 1993; 5: 40.
37. Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 2001; 358: 801-7.
38. Julien J, Denier C, Ferrer X, Ducros A, Saintarailles J, Lagueny A, et al. Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease? J Neurol 2001; 248: 209-14.
39. Klein A, Boltshauser E, Jen J, Baloh RW. Episodic ataxia type 1 with distal weakness - a novel manifestation of a potassium channelopathy. Neuropediatrics 2004; 35: 147-9.
40. Knight MA, Storey E, McKinlay Gardner RJ, Hand P, Forrest SM. Identification of a novel missense mutation L329I in the episodic ataxia type 1 gene KCNA1-a challenging problem. Hum Mutat 2000; 16: 374.
41. Kramer PL, Yue Q, Gancher ST, Nutt JG, Baloh R, Smith E, et al. A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am J Hum Genet 1995; 57: 182-5.
42. Lee H, Wang H, Jen JC, Sabatti C, Baloh RW, Nelson SF. A novel mutation in KCNA1 causes episodic ataxia without myokymia. Hum Mutat 2004; 24: 536.
43. Litt M, Kramer P, Browne D, Gancher S, Brunt ER, Root D, et al. A gene for episodic ataxia/myokymia maps to chromosome 12p13. Am J Hum Genet 1994; 55: 702-9.
44. Maselli RA, Wan J, Dunne V, Graves M, Baloh RW, Wollmann RL, et al. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 2003; 61: 1743-8.
45. Mori Y, Friedrich T, Kim MS, Mikami A, Nakai J, Ruth P, et al. Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 1991; 350: 398-402.
46. Mori Y, Wakamori M, Oda S, Fletcher CF, Sekiguchi N, Mori E, et al. Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)). J Neurosci 2000; 20: 5654-62.
47. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996; 87: 543-52.
48. Papazian DM, Schwarz TL, Tempel BL, Jan YN, Jan LY. Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila. Science 1987; 237: 749-53.
49. Poujois A, Antoine JC, Combes A, Touraine RL. Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene. J Neurol 2006; 253: 957-9.
50. Resnick JS, Engel WK, Griggs RC, Stam AC. Acetazolamide prophylaxis in hypokalemic periodic paralysis. N Engl J Med 1968; 278: 582-6.
51. Scheffer H, Brunt ER, Mol GJ, van der Vlies P, Stulp RP, Verlind E, et al. Three novel KCNA1 mutations in episodic ataxia type I families. Hum Genet 1998; 102: 464-6.
52. Smart SL, Lopantsev V, Zhang CL, Robbins CA, Wang H, Chiu SY, et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron 1998; 20: 809-19.
53. Soong TW, DeMaria CD, Alvania RS, Zweifel LS, Liang MC, Mittman S, et al. Systematic identification of splice variants in human P/Q-type channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent inactivation. J Neurosci 2002; 22: 10142-52.
54. Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TP. Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol 2004; 56: 213-20.
55. Spacey SD, Materek LA, Szczygielski BI, Bird TD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 2005; 62: 314-6.
56. Steckley JL, Ebers GC, Cader MZ, McLachlan RS. An autosomal dominant disorder with episodic ataxia, vertigo, and tinnitus. Neurology 2001; 57: 1499-502.
57. Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 2003; 61: 165-70.
58. Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 2004; 62: 1623-5.
59. Vahedi K, Joutel A, Van Bogaert P, Ducros A, Maciazeck J, Bach JF, et al. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol 1995; 37: 289-93.
60. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LA, Cesetti T, et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004; 41: 701-10.
61. von Brederlow B, Hahn AF, Koopman WJ, Ebers GC, Bulman DE. Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet 1995; 4: 279-84.
62. Walter JT, Alvina K, Womack MD, Chevez C, Khodakhah K. Decreases in the precision of Purkinje cell pacemaking cause cerebellar dysfunction and ataxia. Nat Neurosci 2006; 9: 389-97.
63. Wan J, Carr JR, Baloh RW, Jen JC. Nonconsensus intronic mutations cause episodic ataxia. Ann Neurol 2005a; 57: 131-5.
64. Wan J, Khanna R, Sandusky M, Papazian DM, Jen JC, Baloh RW. CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics. Neurology 2005b; 64: 2090-7.
65. Wang H, Kunkel DD, Schwartzkroin PA, Tempel BL. Localization of Kv1.1 and Kv1.2, two K channel proteins, to synaptic terminals, somata, and dendrites in the mouse brain. J Neurosci 1994; 14: 4588-99.
66. Weisz CJ, Raike RS, Soria-Jasso LE, Hess EJ. Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering. J Neurosci 2005; 25: 4141-5.
67. Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005; 434: 640-4.
68. Yue Q, Jen JC, Nelson SF, Baloh RW. Progressive ataxia due to a missense mutation in a calcium-channel gene. Am J Hum Genet 1997; 61: 1078-87.
69. Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, et al. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. Nat Genet 1997; 15: 62-9.
70. Zuberi SM, Eunson LH, Spauschus A, De Silva R, Tolmie J, Wood NW, et al. A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 1999; 122: 817-25.
71. Zwingman TA, Neumann PE, Noebels JL, Herrup K. Rocker is a new variant of the voltage-dependent calcium channel gene Cacna1a. J Neurosci 2001; 21: 1169-78.